|
CVRX | Cvrx, Inc. |
|
|
CVRX | Cvrx, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.67 |
| Leverage | 46.65% |
| Market Cap | $ 315.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -51.4m |
| Margin | -90.63% |
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.